1. Home
  2. CDNA vs EXPI Comparison

CDNA vs EXPI Comparison

Compare CDNA & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$6.74

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
EXPI
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2007
2010

Fundamental Metrics

Financial Performance
Metric
CDNA
EXPI
Price
$21.60
$6.74
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$28.00
$9.75
AVG Volume (30 Days)
652.5K
921.3K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
N/A
3.18%
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$48,324,000.00
$500,147,681.00
Revenue This Year
$16.01
$6.26
Revenue Next Year
$11.31
$5.50
P/E Ratio
$429.80
N/A
Revenue Growth
18.93
220.39
52 Week Low
$10.96
$5.66
52 Week High
$23.24
$12.23

Technical Indicators

Market Signals
Indicator
CDNA
EXPI
Relative Strength Index (RSI) 59.06 60.03
Support Level $15.80 $5.68
Resistance Level $22.89 $6.87
Average True Range (ATR) 1.00 0.23
MACD -0.06 0.04
Stochastic Oscillator 76.54 81.56

Price Performance

Historical Comparison
CDNA
EXPI

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.

Share on Social Networks: